Zixiong Zhu - Publications

Dapagliflozin alleviates isoprenaline-induced cardiac hypertrophy by promoting mitophagy via AMPKα2 signaling pathway.

Journal: Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology

Published: February 26, 2025

Impact of low environmental temperatures on the global burden of myocarditis: insights from the 1990-2021 global burden of disease study.

Journal: BMC cardiovascular disorders

Published: January 26, 2025

The Role of AMPKα in the Mechanism of Development and Treatment of Heart Failure.

Journal: Reviews in cardiovascular medicine

Published: December 17, 2024

Global burden of myocarditis in youth and middle age (1990-2019): A systematic analysis of the disease burden and thirty-year forecast.

Journal: Current problems in cardiology

Published: June 26, 2024

Global trends and projections of high BMI burden and its independent impact on atrial fibrillation and flutter.

Journal: International health

Published: June 15, 2024

Association between blood inflammatory indices and heart failure: a cross-sectional study of NHANES 2009-2018.

Journal: Acta cardiologica

Published: May 21, 2024

Analysis of Inclisiran in the US FDA Adverse Event Reporting System (FAERS): a focus on overall patient population and sex-specific subgroups.

Journal: Expert opinion on drug safety

Published: April 27, 2024

Non-alcoholic fatty liver disease and heart failure: A comprehensive bioinformatics and Mendelian randomization analysis.

Journal: ESC heart failure

Published: April 18, 2024